SINONASAL CARCINOMA
Clinical trials for SINONASAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo offers hope for rare sinus cancer that can't be removed
Disease control Recruiting nowThis study tests whether a combination of two drugs (becotatug vedotin and epirubicin) can shrink a rare type of sinus cancer that has come back and cannot be surgically removed. About 40 adults with EGFR-positive adenoid cystic carcinoma will receive the treatment to see if it m…
Matched conditions: SINONASAL CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 04:40 UTC
-
New chemo strategy aims to shrink rare sinus tumors and avoid major surgery
Disease control Recruiting nowThis study is for people with a rare and hard-to-treat sinus cancer called sinonasal adenoid cystic carcinoma. Researchers are testing a method where a high dose of the chemotherapy drug epirubicin is delivered directly to the tumor through a small tube in an artery. After three …
Matched conditions: SINONASAL CARCINOMA
Phase: PHASE2 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 04:30 UTC
-
New study aims to uncover the secrets of sinonasal cancer
Knowledge-focused Recruiting nowThis study follows 200 people with sinonasal cancer to see how their disease progresses, how well treatments work, and how their quality of life changes over time. Researchers will also analyze tumor tissue to understand the genetic makeup of these cancers. The goal is to gather …
Matched conditions: SINONASAL CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC